ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Inhibition of lncRNA KCNQ1OT1 Improves Apoptosis and Chemotherapy Drug Response in Small Cell Lung Cancer by TGF-β1 Mediated Epithelial-to-Mesenchymal Transition

Li, Deyu; Tong, Qin; Lian, Yuane; Chen, Zhizhong; Zhu, Yaru; Huang, Weimei; Wen, Yang; Wang, Qiongyao; Liang, Shumei; Li, Man; Zheng, Jianjing; Liu, Zhenhua*; Liu, Huanxin*; Guo, Linlang*广州医学院; 南方医科大学; 1
Cancer Research and Treatment2021-10DOI: 10.4143/crt.2020.1208
4被引5阅读
引用收藏
分享

摘要

Purpose Drug resistance is one of the main causes of chemotherapy failure in patients with small cell lung cancer (SCLC), and extensive biological studies into chemotherapy drug resistance are required. Materials and Methods In this study, we performed lncRNA microarray, in vitro functional assays, in vivo models and cDNA microarray to evaluate the impact of lncRNA in SCLC chemoresistance. Results The results showed that KCNQ1OT1 expression was upregulated in SCLC tissues and was a poor prognostic factor for patients with SCLC. Knockdown of KCNQ1OT1 inhibited cell proliferation, migration, chemoresistance and promoted apoptosis of SCLC cells. Mechanistic investigation showed that KCNQ1OT1 can activate transforming growth factor-beta 1 mediated epithelial-tomesenchymal transition in SCLC cells. Conclusion Taken together, our study revealed the role of KCNQ1OT1 in the progression and chemoresistance of SCLC, and suggested KCNQ1OT1 as a potential diagnostic and prognostic biomarker in SCLC clinical management.

学科与关键词

关键词
LncRNAKCNQ1OT1Small cell lung cancerPrognosticChemotherapy
相关
加载中…
  • KCNQ1OT1 lncRNA affects the proliferation, apoptosis, and chemoresistance of small cell lung cancer cells via the JAK2/STAT3 axis
    Zhu, Yaru; Shen, Yefeng; Chen, Rui; Li, Hui; Wu, Yuanzhou; Zhang, Fuwei; Huang, Weimei; Guo, Linlang; Chen, Qunqing*; Liu, Huanxin*Annals of Translational Medicine, 2021, 9(10): 891.被引 18
  • Biological role of long non-coding RNA KCNQ1OT1 in cancer progression
    Zhan, Kai; Pan, Huafeng; Zhou, Zhang; Tang, Wenqian; Ye, Zhining; Huang, Shaogang; Luo, Lei*Biomedicine and Pharmacotherapy, 2023, 169: 115876.
  • Identification of key genes and pathway related to chemoresistance of small cell lung cancer through an integrative bioinformatics analysis
    Zeng, Fan-Rui; Zhou, Xu-Yang; Zeng, Ling-Ge; Sun, Jian-Cong; He, Fen; Mo, Wei; Wen, Yang; Wang, Shu-Yu; Liu, Qin; Guo, Lin-Lang*Annals of Translational Medicine, 2022, 10(18): 968.被引 1
查看全部 →

发表信息

论文状态
公开发表
期刊
Cancer Research and Treatment
发表日期
2021-10
卷期
第 53 卷, 第 4 期
页码
1042-1056
DOI
10.4143/crt.2020.1208
语言
ENGLISH
期刊收录
NSL
期刊等级
2区
成果收录
SCIE
资助标注
Natural Science Foundation of Guang-dong Province [2016A030313137]; Special Grant for Education and Scientific Research of Fujian Provincial Department of Finance (Fujian Finance Document) [(2019) 926]

作者

  • L

    Li, Deyu (第一作者)

    southern med univ · fujian med univ · fujian prov hosp

  • T

    Tong, Qin

    1 · univ south china

查看全部 14 位作者收起作者
  • L

    Lian, Yuane

    fujian med univ

  • C

    Chen, Zhizhong

    fujian med univ · fujian prov hosp

  • Z

    Zhu, Yaru

    southern med univ

  • H

    Huang, Weimei

    southern med univ

  • W

    Wen, Yang

    southern med univ

  • W

    Wang, Qiongyao

    southern med univ

  • L

    Liang, Shumei

    southern med univ

  • L

    Li, Man

    southern med univ

  • Z

    Zheng, Jianjing

    fujian med univ · fujian prov hosp

  • L

    Liu, Zhenhua (通讯)

    fujian med univ · fujian prov hosp

  • L

    Liu, Huanxin (通讯)

    guangzhou med univ

  • G

    Guo, Linlang (通讯)

    southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417